Published in Mol Cell Proteomics on May 03, 2016
Phase Transition of the Bacterium upon Invasion of a Host Cell as a Mechanism of Adaptation: a Mycoplasma gallisepticum Model. Sci Rep (2016) 0.86
Large scale analysis of amino acid substitutions in bacterial proteomics. BMC Bioinformatics (2016) 0.75
Quantitative proteomics reveals Piccolo as a candidate serological correlate of recovery from Guillain-Barré syndrome. Oncotarget (2016) 0.75
Respiratory Pathways Reconstructed by Multi-Omics Analysis in Melioribacter roseus, Residing in a Deep Thermal Aquifer of the West-Siberian Megabasin. Front Microbiol (2017) 0.75
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol (2001) 24.36
ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat Biotechnol (2014) 13.40
The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res (2012) 13.14
Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med (2003) 10.82
Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet (2016) 10.08
Guillain-Barré syndrome. Lancet (2005) 8.73
Allergic neuritis: an experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvants. J Exp Med (1955) 5.81
The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore) (1969) 4.72
Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin. J Cell Biol (1990) 3.81
The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology (1998) 3.13
IMGT/LIGM-DB, the IMGT comprehensive database of immunoglobulin and T cell receptor nucleotide sequences. Nucleic Acids Res (2006) 2.82
Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barré syndrome. Neurology (2014) 2.77
Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol (1998) 2.47
Guillain-Barré syndrome: an update. J Clin Neurosci (2009) 2.46
Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc Natl Acad Sci U S A (2010) 2.36
eulerAPE: drawing area-proportional 3-Venn diagrams using ellipses. PLoS One (2014) 2.26
The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome. J Clin Invest (2004) 2.25
Axonal prion protein is required for peripheral myelin maintenance. Nat Neurosci (2010) 2.25
Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine (2010) 1.99
Spread of herpes simplex virus in peripheral nerves. Acta Neuropathol (1971) 1.87
Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis. Ann Neurol (1993) 1.85
Vascular leakage in the dorsal root ganglia of the rat, studied with horseradish peroxidase. J Neurol Sci (1976) 1.71
Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology (2011) 1.67
Guillain-Barré syndrome following primary cytomegalovirus infection: a prospective cohort study. Clin Infect Dis (2011) 1.60
Increased risk of Guillain-Barré Syndrome following recent herpes zoster: a population-based study across Taiwan. Clin Infect Dis (2010) 1.59
Pathology of the Guillain-Barré syndrome. Ann Neurol (1981) 1.53
Nodal proteins are target antigens in Guillain-Barré syndrome. J Peripher Nerv Syst (2012) 1.51
Integrated analysis of the cerebrospinal fluid peptidome and proteome. J Proteome Res (2007) 1.49
Review of the activation of TGF-beta in immunity. J Leukoc Biol (2008) 1.35
Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol (1996) 1.34
Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen. Proc Natl Acad Sci U S A (2005) 1.28
Quantifying the association between Campylobacter infection and Guillain-Barré syndrome: a systematic review. J Health Popul Nutr (2010) 1.21
Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis. J Immunol (2008) 1.21
Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis. Brain (2008) 1.20
Transforming growth factor-beta 1 regulates axon/Schwann cell interactions. J Cell Biol (1995) 1.14
Guillain-Barré syndrome. Neurol Sci (2006) 1.12
Anti-neurofascin antibody in patients with combined central and peripheral demyelination. Neurology (2013) 1.11
TGF-β: guardian of T cell function. J Immunol (2013) 1.10
The intrathecal humoral immune response: laboratory analysis and clinical relevance. Clin Chem Lab Med (2001) 1.01
Ganglioside mimicry and peripheral nerve disease. Muscle Nerve (2007) 1.01
Th1/Th2/Th17/Treg cytokines in Guillain-Barré syndrome and experimental autoimmune neuritis. Cytokine Growth Factor Rev (2013) 1.01
Guillain-Barré syndrome: clinical and immunological aspects. Springer Semin Immunopathol (1995) 0.96
Pathogenesis of neuroimmunologic diseases. Experimental models. Immunol Res (1998) 0.95
Combinatorial antibody library from multiple sclerosis patients reveals antibodies that cross-react with myelin basic protein and EBV antigen. FASEB J (2011) 0.93
Proteomic identification of potential protein markers in cerebrospinal fluid of GBS patients. Eur J Neurol (2007) 0.92
A new animal model of spontaneous autoimmune peripheral polyneuropathy: implications for Guillain-Barré syndrome. Acta Neuropathol Commun (2014) 0.90
Proteomics of human cerebrospinal fluid - the good, the bad, and the ugly. Proteomics Clin Appl (2007) 0.90
Peptidome analysis of cerebrospinal fluid by LC-MALDI MS. PLoS One (2012) 0.90
Isolated blood-cerebrospinal fluid barrier dysfunction: prevalence and associated diseases. J Neurol (2005) 0.89
Comparative proteomics analysis of cerebrospinal fluid of patients with Guillain-Barré syndrome. Cell Mol Neurobiol (2008) 0.88
Analyses of transthyretin concentration in the cerebrospinal fluid of patients with Guillain-Barré syndrome and other neurological disorders. Clin Chim Acta (2009) 0.84
Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. Acta Neurol Scand (2011) 0.83
Axonal Guillain-Barré syndrome: carbohydrate mimicry and pathophysiology. J Peripher Nerv Syst (2007) 0.83
Guillain-Barré syndrome. Pediatr Rev (2012) 0.82
Herpes simplex virus and Guillain-Barré polyradiculitis. Br Med J (1975) 0.81
Protein profiling of Guillain-Barrè syndrome cerebrospinal fluid by two-dimensional electrophoresis and mass spectrometry. Neurosci Lett (2010) 0.81
Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies. Autoimmun Rev (2014) 0.81
Microscale depletion of high abundance proteins in human biofluids using IgY14 immunoaffinity resin: analysis of human plasma and cerebrospinal fluid. Anal Bioanal Chem (2014) 0.80
Elevated number of cells secreting transforming growth factor beta in Guillain-Barré syndrome. APMIS (2003) 0.80
Harmful effects of anti-GalNAc-GD1a antibodies and TNF-alpha on rat dorsal root ganglia. J Peripher Nerv Syst (2005) 0.79
Flow cytometric analysis of infiltrating cells in the peripheral nerves in experimental allergic neuritis. J Neuroimmunol (2000) 0.79
Correlations between cytomegalovirus, Epstein-Barr virus, anti-ganglioside antibodies, electrodiagnostic findings and functional status in Guillain-Barré syndrome. Iran J Neurol (2014) 0.78
Neurofascin antibodies in inflammatory neuropathy: how many needles make a haystack? Neurology (2012) 0.78
Proteome analysis of cerebrospinal fluid in Guillain-Barré syndrome (GBS). J Neuroimmunol (2007) 0.78
Ranvier revisited: novel nodal antigens stimulate interest in GBS pathogenesis. Neurology (2014) 0.78
Expression of TNFalpha and TGFbeta1 in Guillain-Barré syndrome: correlation of a low TNFalpha-/TGFbeta1-mRNA ratio with good recovery and signs for immunoregulation within the cerebrospinal fluid compartment. Eur J Neurol (2000) 0.77
Electrodiagnosis of GBS subtypes by a single study: not yet the squaring of the circle. J Neurol Neurosurg Psychiatry (2014) 0.77
Different mechanisms of inflammation induced in virus and autoimmune-mediated models of multiple sclerosis in C57BL6 mice. Biomed Res Int (2013) 0.76
Heavy-light chain interrelations of MS-associated immunoglobulins probed by deep sequencing and rational variation. Mol Immunol (2014) 0.76
Is isolation of comprehensive human plasma peptidomes an achievable quest? J Proteomics (2015) 0.76
Autoimmunoreactivity to Schwann cells in patients with inflammatory neuropathies. Brain (2003) 0.75
Primary cytomegalovirus infection in patients with Guillain-Barré syndrome. J Neuroimmunol (2006) 0.75